NFKB1 and breast carcinoma: Other data demonstrated that NF-κB is required for the dex-related protective effect against TNF-α-mediated cell death and correlated with lack of degradation of the anti-apoptotic protein c-IAPI in breast cancer cells [39, 167, 168].